PharmaResearch Co., Ltd. (214450.KQ)
KRW 259500.0
(2.77%)
KRW 259500.0
(2.77%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 50.23 Billion KRW | 105.43% |
| 2022 | 24.45 Billion KRW | 41.0% |
| 2021 | 17.34 Billion KRW | -16.55% |
| 2020 | 20.78 Billion KRW | 49.21% |
| 2019 | 13.92 Billion KRW | 13.29% |
| 2018 | 12.29 Billion KRW | 140.18% |
| 2017 | 5.11 Billion KRW | -6.0% |
| 2016 | 5.44 Billion KRW | 13.84% |
| 2015 | 4.78 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 51.33 Billion KRW | 2.2% |
| 2024 Q2 | 53.28 Billion KRW | 3.79% |
| 2023 FY | 50.23 Billion KRW | 105.43% |
| 2023 Q2 | 41.13 Billion KRW | 52.66% |
| 2023 Q1 | 26.94 Billion KRW | 10.2% |
| 2023 Q3 | 49.87 Billion KRW | 21.24% |
| 2023 Q4 | 50.23 Billion KRW | 0.72% |
| 2022 Q3 | 21.37 Billion KRW | 18.94% |
| 2022 Q4 | 24.45 Billion KRW | 14.41% |
| 2022 FY | 24.45 Billion KRW | 41.0% |
| 2022 Q2 | 17.97 Billion KRW | -2.95% |
| 2022 Q1 | 18.51 Billion KRW | 6.78% |
| 2021 FY | 17.34 Billion KRW | -16.55% |
| 2021 Q1 | 19.97 Billion KRW | -3.88% |
| 2021 Q4 | 17.34 Billion KRW | -16.27% |
| 2021 Q3 | 20.71 Billion KRW | 8.23% |
| 2021 Q2 | 19.13 Billion KRW | -4.2% |
| 2020 Q3 | 22.98 Billion KRW | 20.87% |
| 2020 FY | 20.78 Billion KRW | 49.21% |
| 2020 Q4 | 20.78 Billion KRW | -9.59% |
| 2020 Q1 | 16.55 Billion KRW | 18.89% |
| 2020 Q2 | 19.01 Billion KRW | 14.83% |
| 2019 Q3 | 11.48 Billion KRW | -1.2% |
| 2019 FY | 13.92 Billion KRW | 13.29% |
| 2019 Q4 | 13.92 Billion KRW | 21.28% |
| 2019 Q2 | 11.62 Billion KRW | -3.97% |
| 2019 Q1 | 12.1 Billion KRW | -1.54% |
| 2018 Q1 | 9.13 Billion KRW | 78.42% |
| 2018 FY | 12.29 Billion KRW | 140.18% |
| 2018 Q4 | 12.29 Billion KRW | 42.17% |
| 2018 Q3 | 8.64 Billion KRW | -5.23% |
| 2018 Q2 | 9.12 Billion KRW | -0.09% |
| 2017 Q3 | 7.08 Billion KRW | 49.36% |
| 2017 Q2 | 4.74 Billion KRW | -16.77% |
| 2017 Q1 | 5.7 Billion KRW | 4.74% |
| 2017 Q4 | 5.11 Billion KRW | -27.8% |
| 2017 FY | 5.11 Billion KRW | -6.0% |
| 2016 Q3 | 5.99 Billion KRW | 0.0% |
| 2016 Q1 | - KRW | -100.0% |
| 2016 Q4 | 5.44 Billion KRW | -9.16% |
| 2016 FY | 5.44 Billion KRW | 13.84% |
| 2015 FY | 4.78 Billion KRW | 0.0% |
| 2015 Q4 | 4.78 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Co., Ltd. | 11.42 Billion KRW | -339.803% |
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -4868.07% |
| BINEX Co., Ltd. | 28.26 Billion KRW | -77.742% |
| Bioneer Corporation | 41.35 Billion KRW | -21.468% |
| Anterogen.Co.,Ltd. | 1.91 Billion KRW | -2529.271% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | -246.027% |
| CrystalGenomics, Inc. | 1.55 Billion USD | -3130.81% |
| Helixmith Co., Ltd | 914.11 Million KRW | -5395.197% |
| Chabiotech Co.,Ltd. | 34.11 Billion KRW | -47.237% |
| Medy-Tox Inc. | 59.61 Billion KRW | 15.743% |
| Peptron, Inc. | 172.18 Million KRW | -29073.085% |
| Amicogen, Inc. | 46.83 Billion KRW | -7.248% |
| Genexine, Inc. | 3.8 Billion KRW | -1219.497% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | -841.418% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | -25420.116% |
| ALTEOGEN Inc. | 1.06 Billion KRW | -4601.824% |
| SillaJen, Inc. | 1.21 Billion KRW | -4042.45% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | -294.26% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | -10624.033% |
| Genomictree Inc. | 496.53 Million KRW | -10016.654% |
| MedPacto, Inc. | 620.00 KRW | -8101994345.0% |
| D&D Pharmatech | 3.45 Billion KRW | -1355.918% |
| EASY BIO,Inc. | 25.93 Billion KRW | -93.659% |
| GI Innovation, Inc. | - KRW | -Infinity% |